Sneaking a peak at evolution's recipe book
23 January, 2007 by Kate McDonaldEvolution is being harnessed for modern drug development by West Australian biotech Phylogica.
Big Pharmas collaborate on diabetes
17 January, 2007 by Staff WritersAstraZeneca and Bristol-Myers Squib have joined forces to develop two compounds to treat type 2 diabetes.
Merck wins Vioxx case
17 November, 2006 by ABN StaffDrug maker Merck & Co has won another lawsuit over its Vioxx painkiller.
DNA and protein identification in the same device?
16 November, 2006 by ABN StaffA prototype device that could enable both DNA and protein identification and measurement in a single sample at the same time has received the backing of US giant Applied Biosystems.
The future is small: nanotech meets biotech
15 November, 2006 by John KapelerisThe convergence of nanotechnology with biotechnology will be one of the hot topics of AusBiotech 2006. Dr John Kapeleris takes a look at recent developments in nanotechnology and how they may be put to use in the biotech world.
How green is our valley
15 November, 2006 by Graeme O'NeillAustralia's much maligned native grasses have come in for a make-over in recent years. And as Graeme O'Neill reports, they needn't weep anymore.
Prometheus unbound: caveolin and liver regeneration
10 November, 2006 by Fiona WylieIt could be a long way off before we can take a 'caveolin pill' to fix our livers after a big night out, but a recent breakthrough by collaborating scientists in Brisbane and Barcelona has brought the possibility a little closer, as Fiona Wylie reports.
Faster ways to identify fruit flies
06 November, 2006 by ABN StaffA team at the Elizabeth Macarthur Agricultural Institute (EMAI) in NSW is developing an automated, rapid diagnostic system to genotype fruit flies.
How Chemeq hopes to save its bacon
25 September, 2006 by Kate McDonaldThe last couple of years have been rather disastrous for West Australian biotech Chemeq, manufacturer of polymer microbials for pigs and poultry. However, a new management team has come up with a plan to turn its fortunes around, as Kate McDonald reports.
New chair gives the goods on NHMRC
21 September, 2006 by Fiona WylieFederal Health Minister Tony Abbott recently announced the 19 members of the National Health and Medical Research Council (NHMRC) for the next three years, presenting the head of one of Australia's largest medical research institutes, Professor Michael Good, with an unexpected but very welcome new challenge. Fiona Wylie reports.
Wnt and the tissue-regeneration symphony
21 September, 2006 by Graeme O'NeillIs it possible to re-awaken dormant pathways in humans to regenerate tissue? Graeme O'Neill talks to Professor Randall Moon about the Wnt family of cell-signalling proteins.
Array CGH enters the realm of clinical diagnostics
21 September, 2006 by Kate McDonaldThe power of array CGH to detect chromosomal losses and gains across the genome is sparking moves into clinical diagnostics, as Kate McDonald reports.
Out of Africa: the future of GM crops
21 September, 2006 by Graeme O'NeillNowhere is the potential of agricultural biotechnology and GM crops more obvious than in Africa, as Graeme O'Neill reports.
The green gene revolution in India
21 September, 2006 by Graeme O'NeillGM giant Monsanto may be the bete noire of the anti-GM movement, but its scientists, particularly in India, are moving ahead with the Green Revolution, as Graeme O'Neill reports.
TraitMill: serial cereal phenotyping
21 September, 2006 by Graeme O'NeillAn enormous, high-security greenhouse in the countryside 20km north of Ghent in Belgium hints at the high-technology future of crop breeding in the 21st century. Graeme O'Neill reports.
